CRC 1450 - B02: Quantitative MRI of organ-specific vascular permeability and immune cell dynamics by combination with mass spectrometric imaging

Basic data for this project

Type of projectSubproject in DFG-joint project hosted at University of Münster
Duration at the University of Münster01/01/2021 - 31/12/2024 | 1st Funding period

Description

The aim of this project is to develop combined in vivo MRI and ex vivo mass spectrometry imaging (MSI) methods including both, laser ablation-inductively coupled plasma-mass spectrometry imaging (LA-ICP-MSI) and matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI). MSI shall be used to develop fully quantitative MRI methods as part of our comprehensive multiscale imaging strategy to analyse immune responses in disease models and patients in vivo. The overarching question is how quantitative MR parameters depend on elemental and molecular patterns in tissues, and how this dependence evolves during inflammatory responses.

KeywordsMRI; mass spectrometry; Radiology; Nuclear Medicine; Radiotherapy; Radiobiology
Website of the projecthttps://www.uni-muenster.de/CRC-inSight/research/area-B/B02.php
Funding identifierSFB 1450/1, B02
Funder / funding scheme
  • DFG - Collaborative Research Centre (SFB)

Project management at the University of Münster

Faber, Cornelius Joachim
Clinic of Radiology
Karst, Uwe
Professur für Analytische Chemie (Prof. Karst)

Applicants from the University of Münster

Faber, Cornelius Joachim
Clinic of Radiology
Karst, Uwe
Professur für Analytische Chemie (Prof. Karst)